Vijayakanth Pagadala

Vijayakanth Pagadala

Auto-generated profile, based on publicly available information

Vijayakanth Pagadala

Glycan Therapeutics Corp., 617 Hutton Street, Raleigh, NC 27606, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2012 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
JSJindrich Symersky
Jindrich Symersky
VPVijayakanth Pagadala
Vijayakanth Pagadala
DODaniel Osowski
Daniel Osowski
AKAlexander Krah
Alexander Krah
TMThomas Meier
Thomas Meier
DMDavid M Mueller
David M Mueller
The membrane-embedded c-ring allows the passage of protons to power the synthesis of ATP by the FoF1 ATPase. Previous structural data have shown the proton acceptor-donor sites in a closed, ion-locked conformation. Structural and computational data now reveal the open conformation of the yeast mitochondrial c10 ring. The proton pore of the F1Fo ATP synthase consists of a ring of c subunits, which rotates, driven by downhill proton diffusion across the membrane. An essential carboxylate side chain in each subunit provides a proton-binding site. In all the structures of c-rings reported to date, these sites are in a closed, ion-locked state. Structures are here presented of the c10 ring from Saccharomyces cerevisiae determined at pH 8.3, 6.1 and 5.5, at resolutions of 2.0 Å, 2.5 Å and 2.0 Å, respectively. The overall structure of this mitochondrial c-ring is similar to known homologs, except that the essential carboxylate, Glu59, adopts an open extended conformation. Molecular dynamics simulations reveal that opening of the essential carboxylate is a consequence of the amphiphilic nature of the crystallization buffer. We propose that this new structure represents the functionally open form of the c subunit, which facilitates proton loading and release.

6 September 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
YXYongmei Xu
Yongmei Xu
KCKasemsiri Chandarajoti
Kasemsiri Chandarajoti
XZXing Zhang
Xing Zhang
VPVijayakanth Pagadala
Vijayakanth Pagadala
WDWenfang Dou
Wenfang Dou
JLJian Liu
Jian Liu
A synthetic homogeneous low–molecular weight heparin provides a safe and effective therapeutic alternative.

21 September 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
XZXing Zhang
Xing Zhang
VPVijayakanth Pagadala
Vijayakanth Pagadala
HJHannah M. Jester
Hannah M. Jester
ALAndrew M. Lim
Andrew M. Lim
TPTruong Quang Pham
Truong Quang Pham
RLRobert Linhardt
Robert Linhardt
Heparan sulfate (HS) is a member of the glycosaminoglycans (GAG) family that plays essential roles in biological processes from animal sources. Heparin, a highly sulfated form of HS, is widely used as anticoagulant drug worldwide. The high diversity and complexity of HS and heparin represent a roadblock for structural characterization and biological activity studies. Access to structurally defined oligosaccharides is critical for the successful development of HS and heparin structure–activity relationships. In this study, a library of 66 HS and heparin oligosaccharides covering different sulfation patterns and sizes was prepared through an efficient method of chemoenzymatic synthesis. A systematic nuclear magnetic resonance spectroscopy study was firstly undertaken for every oligosaccharide in the library. In addition to the availability of different oligosaccharides, this work also provides spectroscopic data helpful for characterizing more complicated polysaccharide structures providing a safeguard to ensure the quality of the drug heparin. This HS/heparin library will be useful for activity screening and facilitate future structure–activity relationship studies.

18 March 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
Katelyn ArnoldKatelyn Arnold
Katelyn Arnold
YXYongmei Xu
Yongmei Xu
ESErica M. Sparkenbaugh
Erica M. Sparkenbaugh
MLMiaomiao Li
Miaomiao Li
XHXiaorui Han
Xiaorui Han
JLJian Liu
Jian Liu
Acetaminophen/paracetamol (APAP) overdose is the leading cause of drug-induced acute liver failure (ALF) in the United States and Europe. The progression of the disease is attributed to sterile inflammation induced by the release of high mobility group box 1 (HMGB1) and the interaction with receptor for advanced glycation end products (RAGE). A specific, effective, and safe approach to neutralize the proinflammatory activity of HMGB1 is highly desirable. Here, we found that a heparan sulfate (HS) octadecasaccharide (18-mer-HP or hepatoprotective 18-mer) displays potent hepatoprotection by targeting the HMGB1/RAGE axis. Endogenous HS proteoglycan, syndecan-1, is shed in response to APAP overdose in mice and humans. Furthermore, purified syndecan-1, but not syndecan-1 core protein, binds to HMGB1, suggesting that HMGB1 binds to HS polysaccharide side chains of syndecan-1. Last, we compared the protection effect between 18-mer-HP and N-acetyl cysteine, which is the standard of care to treat APAP overdose. We demonstrated that 18-mer-HP administered 3 hours after a lethal dose of APAP is fully protective; however, the treatment of N-acetyl cysteine loses protection. Therefore, 18-mer-HP may offer a potential therapeutic advantage over N-acetyl cysteine for late-presenting patients. Synthetic HS provides a potential approach for the treatment of APAP-induced ALF.

6 April 2015 in Microbial Cell
Verified
Journal Article
Open access
TXTing Xu
Ting Xu
VPVijayakanth Pagadala
Vijayakanth Pagadala
DMDavid M. Mueller
David M. Mueller
Understanding structure, function, and mutations in the mitochondrial ATP synthase –

26 May 2023 in Science Advances
Verified
Journal Article
Closed access
ZWZhangjie Wang
Zhangjie Wang
VPVaishali N. Patel
Vaishali N. Patel
XSXuehong Song
Xuehong Song
YXYongmei Xu
Yongmei Xu
AKAndrea Kaminski
Andrea Kaminski
JLJian Liu
Jian Liu
HS3ST1 is a genetic risk gene associated with Alzheimer’s disease (AD) and overexpressed in patients, but how it contributes to the disease progression is unknown. We report the analysis of brain heparan sulfate (HS) from AD and other tauopathies using a LC-MS/MS method. A specific 3- O -sulfated HS displayed sevenfold increase in the AD group ( n = 14, P < 0.0005). Analysis of the HS modified by recombinant sulfotransferases and HS from genetic knockout mice revealed that the specific 3- O -sulfated HS is made by 3- O -sulfotransferase isoform 1 (3-OST-1), which is encoded by the HS3ST1 gene. A synthetic tetradecasaccharide (14-mer) carrying the specific 3- O -sulfated domain displayed stronger inhibition for tau internalization than a 14-mer without the domain, suggesting that the 3- O -sulfated HS is used in tau cellular uptake. Our findings suggest that the overexpression of HS3ST1 gene may enhance the spread of tau pathology, uncovering a previously unidentified therapeutic target for AD.